Long List of BIEL Accomplishments...More to Come *

New Post Public Reply Private Reply Replies (1) Message Board
swordfish
967
Long List of BIEL Accomplishments...More to Come

* 3/5/2019 - CVS adds 27 Stores to its ActiPatch Program in CA:

Store#...… City

9970 …... Buellton
10743 .… Carlsbad
9234 ...…. Fremont
9577 …… Huntington Beach
9552 ...…. Ladera Ranch
3057/9924/8880 .. Laguna Niguel
9541 ……. Lake Forrest
9169 ……. La Mesa
9477/9531/9685 ... Los Angeles
3058 …… Moreno Valley
8866/9532 ………. Oceanside
9299 ……. Pinole
9807 ……. San Bruno
9137 ……. San Diego
9896/9897 ………. San Jose
9558 ……. San Marcos
9145 ……. Santee
9475/9478 ………. Torrance
9855 ……. Tracy
8836 …… Vista

* 2/12/2019 - BIEL files two 510Ks with the FDA, Full Body Female OTC Musculoskeletal Pain and Post Operative Pain OTC.

https://globenewswire.com/news-release/2019/0...-Pain.html

* 11/14/2018 - ActiPatch Knee Product is available in VA Clinics

https://upticknewswire.com/featured-interview...nk-biel-4/

* 9/2018 - A New ActiPatch with a Protex Compression Knee Sleeve is spotted in a US CVS Store, ( thanks 'Penny2017investor' for finding this important information). BIEL Sales VP Keith Nalepka later confirms a 200 store Trial Rollout with CVS. As of March 2019 ActiPatch is still on CVS shelves.

https://upticknewswire.com/featured-interview...nk-biel-4/

* 5/31/2018 - B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program

https://globenewswire.com/news-release/2018/0...ogram.html

* 4/1/2018 - United Kingdom National Health Service added ActiPatch to its Drug Tariff of approved Medical Devices.

https://globenewswire.com/news-release/2018/0...erage.html

* 7/2018-11/2018 - Mundipharma, a Billion dollar global corporation, begins ActiPatch Distribution in Australia, New Zealand, Philippines, Indonesia, Singapore, Thailand, and Malaysia.

https://globenewswire.com/news-release/2018/0...folio.html

https://www.marketwatch.com/press-release/bio...2018-11-15

* 1/9/2018 - BIEL signs Retail Deal with CARE Pharmacies, an association of 100 Independent Pharmacy Stores

http://www.actipatch.com/bioelectronics-and-c...o-opioids/

* 1/22/2018 - BIEL signs Distribution Deal with Billion dollar Performance Health which specializes in Long Term Care/Rehabilitation/Physical Therapy Markets

https://www.performancehealth.com/actipatch-a...ain-relief

* 2/3/2017 – ActiPatch FDA 510k 152432 Cleared for OTC Sales in the US. This puts to rest all of the “scam device” nonsense from BIEL’s detractors. The FDA, the most stringent medical authority on the planet, says that ActiPatch is a safe and effective pain reliever. In a further confirmation of the innovative nature of this Clearance the FDA created a new Classification Product Code, PQY, for ActiPatch.

https://www.accessdata.fda.gov/scripts/cdrh/c...ID=K152432

* 8/22/2017 – Keith Nalepka appointed VP of Sales and Marketing
Mr. Nalepka has 15 years of experience in placing health care products on retail shelves. He knows the store buyers and can get a meeting to present his ActiPatch pitch. BIEL has had several expert doctors on staff but never an “A List” Marketing Expert. This is a game changer. Listen to the interview linked below to get a sense of the quality of BIEL’s new VP.

https://upticknewswire.com/interview-vp-of-sa...pink-biel/

http://www.bielcorp.com/bioelectronics-engage...marketing/

* 12/12/2017 - National US Distribution with ANDA
ANDA, formerly owned by Allergan and sold to Teva Pharmaceutical last year, has over 60,000 US healthcare business related customers. This is a key component of the goal to mainstream the ActiPatch and get it placed on retail shelves across the country.

https://globenewswire.com/news-release/2017/1...ioids.html
(bottom of Opioid PR)

* 5/30/2017 – Independent Migraine Study is Started
Migraine prevention is a massive potential market for ActiPatch with 36 million Americans afflicted by these debilitating headaches.

http://www.bielcorp.com/bioelectronics-announ...e-therapy/

* 11/20/2017 – Recruitment Started for Allay Menstrual Pain Study at Birmingham Women’s Hospital UK
This Study has not received a PR yet. It was mentioned in AW’s 11/20 interview. Birmingham is an NHS Foundation Hospital. “Birmingham Women's and Children's is extremely proud to be a world leader in women's and paediatric healthcare, delivering some of the most advanced treatments, complex surgical procedures and cutting-edge research and development.” Allay opens another huge market for BIEL.

https://upticknewswire.com/featured-interview...nk-biel-2/

* 8/22/2017 – ActiPatch Condensing Back/Knee/Shoulder into One Multi-Purpose Product Secured with Kinesiology Tape
This may not seem like a big deal on the surface. The cost savings of only having to stock, inventory, ship, produce packaging materials for one product are significant. Potential retailers have to love it also, only using up one shelf space rather than 3. The “K Tape” is a popular sports tape and will increase sales of the ActiPatch among the athletic demographic. The number one complaint I receive when giving samples to friends is keeping the device in place, problem now solved.

http://www.bielcorp.com/bioelectronics-presid...rtunities/

* 5/11/2017 - BioElectronics Expands into Tesco in the UK Market
A very important door has opened for BIEL with this deal as Tesco is number 5 in global retail sales with $72 billion.

http://www.bielcorp.com/bioelectronics-expand...uk-market/

* 2/9/2017 – ActiPatch Available on the US Amazon Website
Another key component in Mainstreaming ActiPatch. Amazon is the most popular online store in the US with $136 billion in sales last year. This was implemented 6 days after FDA Clearance.

* 2017 – First ActiPatch Licensing Deal, PharmEvo and Pain Gear
PharmEvo is marketing ActiPatch in Asia as “Pain Gear”. PharmEvo is conducting seminars to introduce doctors to “Pain Gear” and has initiated a “Pain Gear” 200 person Clinical Study. PharmEvo is in the business of providing Clinical Trials which may prove very useful to BIEL. PharmEvo is a component of the Premier Group which has business partnerships with the likes of Novartis, Sanofi, GSK and Pfizer.

https://www.marketscreener.com/BIOELECTRONICS...-25495588/

* 12/7/2017 – BIEL Initiates US “Try and Tell” Program, Free 7 Day Trial ActiPatch. This is the same program that created thousands of repeat customers in the UK with a low marketing cost. This will also give BIEL a pool of US consumer Real World Data to reference in future regulatory submissions.

https://globenewswire.com/news-release/2017/1...ogram.html

* 10/26/2017 – POTUS Declares Opioid Crisis a Public Health Emergency
11/6/2017 – BIEL Announces Drug Free Solution to the Opioid Crisis
BIEL promotes ActiPatch as a safe, drug free solution to chronic pain making 5,000 free Trial Devices available.

http://www.bielcorp.com/bioelectronics-announ...actipatch/

* 6/29/2017 – BIEL Announces Health Economics Study
This Study proves that health providers can save resources and provide improved care by using the ActiPatch to manage chronic pain. Healthcare insurers and government health agencies like the NHS should be all over this as they are constantly under pressure to provide better healthcare at a lower cost.

http://www.bielcorp.com/bioelectronics-announ...ics-study/

* 10/27/2017 – ActiPatch Reduces C Section Pain and Drug Use
ActiPatch users following C Section Deliveries had significantly less pain and used half the pain drugs that the control group did.

http://www.actipatch.com/actipatch/wp-content...-Study.pdf

http://www.actipatch.com/support/for-medical-professionals/

* 10/13/2015 - FDA Reclassification of BIEL products from Class 3 to Class 2. This confirmed that SWT Devices were Low Risk and made the 2/3/2017 OTC Clearance possible.

https://www.federalregister.gov/documents/201...ceforth-to

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 68

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 90

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 78

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 8

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 12

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 133

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Hoymiles Brings Plug-In Solar Flexibility to RE+ 2026

Updated Category News Views 70

A 1.8-kilogram box may not sound like much, but it captures where household solar is trying to go: smaller, less intimidating, and far easier to put to work. At RE+ 2026 in Las Vegas, Hoymiles laid out a residential lineup spanning plug-in solar, battery storage and conventional rooftop microinverters. This was not one flashy gadget looking for applause. It was a fairly...

Continue Reading

Top 5 Most Recently Viewed Articles

JPMorgan's Jamie Dimon Advocates for Office Work Among Feds

Updated Category News Views 130

JPMorgan's Jamie Dimon Advocates for Federal Employees to Return Jamie Dimon, the CEO of JPMorgan Chase, recently expressed his concerns about the numerous vacant offices in Washington, DC, calling on federal employees to head back to their workplaces. His statements have sparked a lively conversation about remote work and its effects on productivity as well as the...

Continue Reading
South Bow’s Robust Q3 2025 Performance and Future Plans

Updated Category News Views 270

South Bow's Third-Quarter Results & 2026 Projections CALGARY, Alberta, Nov. 13, 2025 -- South Bow Corp. (TSX: SOBO & NYSE: SOBO) has disclosed its financial and operational results for the third quarter of 2025 while providing insights about its outlook for 2026. All figures are presented in U.S. dollars unless noted otherwise. Performance Highlights Operational and...

Continue Reading
Smart Logistics Global Limited Completes Successful IPO Funding

Updated Category News Views 174

Smart Logistics Global Limited Successfully Closes IPO Smart Logistics Global Limited (NASDAQ: SLGB), a distinguished logistics solution provider based in Hong Kong, has recently announced the successful completion of its initial public offering (IPO). Through this offering of 1,000,000 ordinary shares priced at $5.00 each, the company generated a total of $5,000,000,...

Continue Reading
Mobilizing Capital to Achieve Sustainability Goals with UN

Updated Category News Views 196

Mobilizing Capital to Achieve Sustainability Goals with UN The UN Global Compact recently hosted a significant forum where over 50 CEOs and representatives convened to strategize on mobilizing private capital for sustainable and inclusive growth. With leaders from various sectors, the forum emphasized how collaboration between the business community and governmental...

Continue Reading
HASA Inc.'s Strategic Acquisition of Bio-Dex Labs

Updated Category News Views 27

Diving into the Pool Chemical Business What a splash in the world of pool chemicals! HASA Inc., the big kahuna in water treatment solutions, just scooped up Bio-Dex Laboratories, a name known far and wide among pool service pros. We're talking a serious step-up in HASA's game, as they integrate this trusted brand's top-notch products into their already hefty lineup. A...

Continue Reading